ESMO Virtual Data Briefing Agenda

ESMO Virtual Data Briefing

14:30 - 15:30 CET
08:30 - 09:30 ET
Tuesday, September 22, 2020


Opening and Welcome Robert LaCaze, Member of the Executive Committee of Bayer’s Pharmaceutical Division and Head of the Oncology Strategic Business Unit
Bayer’s Commitment to Advancing Patient Care Through Research and Innovation Dr. Scott Z. Fields, SVP and Head of Oncology Development at Bayer's Pharmaceuticals Division
Integrated Larotrectinib Analysis: Contextualizing Expanded Data for Patients with TRK Fusion Cancer Professor Ray McDermott, MD, PhD, St. Vincent University Hospital and Tallaght Hospital, Ireland
Pediatric Focus: Understanding Larotrectinib for the Treatment of TRK Fusion Cancer in Children and Adolescents Theodore W. Laetsch, MD, Children’s hospital of Philadelphia, Pennsylvania, USA
Interactive Media Q&A All panelists